341 related articles for article (PubMed ID: 33425157)
1. A review of COVID-19 vaccines in development: 6 months into the pandemic.
Sanicas M; Sanicas M; Diop D; Montomoli E
Pan Afr Med J; 2020; 37():124. PubMed ID: 33425157
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccines: ethical framework concerning human challenge studies.
Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
[TBL] [Abstract][Full Text] [Related]
3. Access considerations for a COVID-19 vaccine for South Africa.
Bangalee V; Suleman F
S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954
[TBL] [Abstract][Full Text] [Related]
4. Improving pandemic preparedness through better, faster influenza vaccines.
Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA
Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708
[No Abstract] [Full Text] [Related]
5. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
Bennet BM; Wolf J; Laureano R; Sellers RS
Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
[TBL] [Abstract][Full Text] [Related]
6. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
7. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
8. The potential neurological effect of the COVID-19 vaccines: A review.
Lu L; Xiong W; Mu J; Zhang Q; Zhang H; Zou L; Li W; He L; Sander JW; Zhou D
Acta Neurol Scand; 2021 Jul; 144(1):3-12. PubMed ID: 33779985
[TBL] [Abstract][Full Text] [Related]
9. Development of vaccines for SARS-CoV-2.
Ng WH; Liu X; Mahalingam S
F1000Res; 2020; 9():. PubMed ID: 32850116
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccines: rapid development, implications, challenges and future prospects.
Kashte S; Gulbake A; El-Amin Iii SF; Gupta A
Hum Cell; 2021 May; 34(3):711-733. PubMed ID: 33677814
[TBL] [Abstract][Full Text] [Related]
11. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
12. Efforts towards a COVID-19 vaccine.
Brüssow H
Environ Microbiol; 2020 Oct; 22(10):4071-4084. PubMed ID: 32893468
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies.
Rawat K; Kumari P; Saha L
Eur J Pharmacol; 2021 Feb; 892():173751. PubMed ID: 33245898
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Development to Vaccination.
Pandey A; Belbase P; Parajuli A
J Nepal Health Res Counc; 2021 Jan; 18(4):807-809. PubMed ID: 33510536
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 basics and vaccine development with a Canadian perspective.
Liu M; Chen X
Can J Microbiol; 2021 Feb; 67(2):112-118. PubMed ID: 33136431
[TBL] [Abstract][Full Text] [Related]
16. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccines: Current Status and Implication for Use in Indonesia.
Ophinni Y; Hasibuan AS; Widhani A; Maria S; Koesnoe S; Yunihastuti E; Karjadi TH; Rengganis I; Djauzi S
Acta Med Indones; 2020 Oct; 52(4):388-412. PubMed ID: 33377885
[TBL] [Abstract][Full Text] [Related]
18. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
Jin P; Li J; Pan H; Wu Y; Zhu F
Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for COVID-19: An Overview.
Lang TF; Eber RM; Reddy MS
Compend Contin Educ Dent; 2021 Jun; 42(6):298-304; quiz 305. PubMed ID: 34077664
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
